Azacitidine and donor lymphocyte infusions as first salvage treatment in patients with acute myeloid leukaemia or myelodysplastic syndromes relapsing after allogeneic stem cell transplantation: interim-analysis from the AZARELA-trial (NCT-00795548)

BONE MARROW TRANSPLANTATION(2011)

引用 0|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要